Search | Page 13 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02566304 ...

    Clinical Trial last updated 04/27/2016 - 1:37pm.

  2. A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT01546038 ...

    Clinical Trial last updated 04/27/2016 - 9:27am.

  3. Microtransplantation to Treat Refractory or Relapsed Hematologic Malignancies in Younger Patients

    ... transplant, patients receive very high doses of chemotherapy and/or radiation therapy, followed by an infusion of their ... bone marrow or blood stem cells . The high-dose chemotherapy drugs and radiation are given to remove the leukemia cells in the ...

    Clinical Trial last updated 05/09/2016 - 3:01pm.

  4. GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant

    ... is to test the safety and benefit of giving a type of chemotherapy - cyclophosphamide - after the transplant to prevent ... induction and at least one course of consolidation chemotherapy pretransplant Patients must have a Karnofsky ...

    Clinical Trial last updated 04/29/2016 - 12:40pm.

  5. Natural Killer (NK) Cells With HLA Compatible Hematopoietic Transplantation for High Risk Myeloid Malignancies

    ... called natural killer (NK) cells that can be given with chemotherapy and a stem cell transplant to patients with AML and ... kill cancer cells that remain in your body after your last chemotherapy treatment. The NK cells will be separated from blood from a ...

    Clinical Trial last updated 06/06/2016 - 1:18pm.

  6. AAMDSIF Emily Kass Research Fund

    ... various treatments and complications, including extreme chemotherapy prior to a bone marrow transplant .  Subsequently, ...

    Research Fund last updated 06/08/2017 - 3:35pm.

  7. Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene

    ... genetically changed immune cells, called T-cells, after chemotherapy will improve the response to a stem cell transplant . ... received an allogeneic stem cell transplant . The chemotherapy participant will be given on study is fludarabine , ...

    Clinical Trial last updated 06/06/2016 - 12:41pm.

  8. Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

    ... - To see if high doses of palifermin before chemotherapy are safe, prevent chronic GVHD, and improve immune function ... catheter if they do not have one. Have 1 3 rounds of chemotherapy. Take more tests to make sure they can have the transplant, ...

    Clinical Trial last updated 04/29/2016 - 1:00pm.

  9. Intra-Osseous Co-Transplant of UCB and hMSC

    ... with hematologic malignancies. Giving low doses of chemotherapy and total-body irradiation before a co-transplant of donor ... by flow cytometry after 2 or more cycles of chemotherapy No complete remission (CR) within 4 weeks of initial ...

    Clinical Trial last updated 05/02/2016 - 11:15am.

  10. T-cell Depleted Alternative Donor Transplantation

    ... patient will receive a conditioning regimen including chemotherapy drugs and/or total body irradiation based on the disease for ... remission but may be enrolled when aplastic after chemotherapy or with < 20% blasts. Patients with lymphoma must be in ...

    Clinical Trial last updated 04/29/2016 - 3:38pm.